Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer’s disease mouse model by regulating the expression of APP secretases

Miaomiao Zhang(Ministry of Education), Weidong Li(Tianjin Medical University)
Alzheimer s Research & Therapy
January 20, 2024
Cited by 36


Related Papers